ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sarcopenia Treatments Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-9I9285
Home | Market Reports | Health| Pharmacy
Global Sarcopenia Treatments Market Size Status and Forecast 2022
BUY CHAPTERS

Global Sarcopenia Treatments Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-9I9285
Report
June 2025
Pages:140
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Nestlé
Pfizer Inc
Amway
By-Health
Usana
A&Z Pharmaceutical
GlaxoSmithKline PLC
Bayer
H&H
Blackmores
Zhendong Group

Sarcopenia Treatments Market Size

In 2024, the global market size of Sarcopenia Treatments was estimated to be worth US$ 3021 million and is forecast to reach approximately US$ 4120 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.

Sarcopenia Treatments Market

Sarcopenia Treatments Market

Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
China is the largest consumption region of Sarcopenia Treatment, with market share nearly 30.83%. The second largest market is United States; following China with the market share of 24.48%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sarcopenia Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sarcopenia Treatments.
The Sarcopenia Treatments market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sarcopenia Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sarcopenia Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Sarcopenia Treatments Market Report

Report Metric Details
Report Name Sarcopenia Treatments Market
CAGR 4.6%
Segment by Type
  • Protein Supplement
  • Calcium Supplement
  • Other
Segment by Application
  • Online Pharmacies
  • Retail Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Nestlé, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline, Bayer, H&H, Blackmores, Zhendong Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Sarcopenia Treatments in global and regional level.
  • Chapter 3: Detailed analysis of Sarcopenia Treatments company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sarcopenia Treatments revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Sarcopenia Treatments Market share by region?

Ans: China is the largest consumption region of Sarcopenia Treatment, with market share nearly 30.83%.

Who are the main players in the Sarcopenia Treatments Market report?

Ans: The main players in the Sarcopenia Treatments Market are Abbott Laboratories, Nestlé, Pfizer, Amway, By-health, Usana, A&Z Pharmaceutical, GlaxoSmithKline, Bayer, H&H, Blackmores, Zhendong Group

What are the Application segmentation covered in the Sarcopenia Treatments Market report?

Ans: The Applications covered in the Sarcopenia Treatments Market report are Online Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Sarcopenia Treatments Market report?

Ans: The Types covered in the Sarcopenia Treatments Market report are Protein Supplement, Calcium Supplement, Other

1 Study Coverage
1.1 Sarcopenia Treatments Product Introduction
1.2 Market by Type
1.2.1 Global Sarcopenia Treatments Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Protein Supplement
1.2.3 Calcium Supplement
1.2.4 Other
1.3 Market by Application
1.3.1 Global Sarcopenia Treatments Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sarcopenia Treatments Market Size Estimates and Forecasts
2.2 Sarcopenia Treatments Market Size by Region: 2024 Versus 2031
2.2.1 Global Sarcopenia Treatments Revenue by Region: 2020-2025
2.2.2 Global Sarcopenia Treatments Revenue Forecast by Region (2026-2031)
2.2.3 Global Sarcopenia Treatments Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Sarcopenia Treatments Revenue by Type (2020-2031)
3.1.2 Global Sarcopenia Treatments Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Sarcopenia Treatments Revenue by Application (2020-2031)
3.2.2 Global Sarcopenia Treatments Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Protein Supplement of Sarcopenia Treatments Revenue Market Share by Application
3.3.2 Calcium Supplement of Sarcopenia Treatments Revenue Market Share by Application
3.3.3 Other of Sarcopenia Treatments Revenue Market Share by Application
4 Global Sarcopenia Treatments by Company
4.1 Global Sarcopenia Treatments Revenue by Company (2020-2025)
4.2 Global Sarcopenia Treatments Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Sarcopenia Treatments Companies around the World: Ranking by Revenue
4.3.2 Global Sarcopenia Treatments Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Sarcopenia Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Sarcopenia Treatments Companies Headquarters & Product Type
4.4.1 Global Sarcopenia Treatments Companies Headquarters
4.4.2 Date of International Companies Enter into Sarcopenia Treatments Market
4.4.3 Global Sarcopenia Treatments Companies Product & Service
4.4.4 Protein Supplement Revenue Market Share of Sarcopenia Treatments by Company
4.4.5 Calcium Supplement Revenue Market Share of Sarcopenia Treatments by Company
4.4.6 Other Revenue Market Share of Sarcopenia Treatments by Company
4.5 Global Sarcopenia Treatments Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Corporation Information
5.1.2 Abbott Laboratories Description, Business Overview
5.1.3 Abbott Laboratories Sarcopenia Treatments Products Offered
5.1.4 Abbott Laboratories Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.1.5 Abbott Laboratories Sarcopenia Treatments Revenue by Product in 2024
5.1.6 Abbott Laboratories Sarcopenia Treatments Revenue by Application in 2024
5.1.7 Abbott Laboratories Sarcopenia Treatments Revenue by Geographic Area in 2024
5.1.8 Abbott Laboratories Recent Developments
5.2 Nestlé
5.2.1 Nestlé Corporation Information
5.2.2 Nestlé Description, Business Overview
5.2.3 Nestlé Sarcopenia Treatments Products Offered
5.2.4 Nestlé Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.2.5 Nestlé Sarcopenia Treatments Revenue by Product in 2024
5.2.6 Nestlé Sarcopenia Treatments Revenue by Application in 2024
5.2.7 Nestlé Sarcopenia Treatments Revenue by Geographic Area in 2024
5.2.8 Nestlé Recent Developments
5.3 Pfizer
5.3.1 Pfizer Corporation Information
5.3.2 Pfizer Description, Business Overview
5.3.3 Pfizer Sarcopenia Treatments Products Offered
5.3.4 Pfizer Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.3.5 Pfizer Sarcopenia Treatments Revenue by Product in 2024
5.3.6 Pfizer Sarcopenia Treatments Revenue by Application in 2024
5.3.7 Pfizer Sarcopenia Treatments Revenue by Geographic Area in 2024
5.3.8 Pfizer Recent Developments
5.4 Amway
5.4.1 Amway Corporation Information
5.4.2 Amway Description, Business Overview
5.4.3 Amway Sarcopenia Treatments Products Offered
5.4.4 Amway Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.4.5 Amway Sarcopenia Treatments Revenue by Product in 2024
5.4.6 Amway Sarcopenia Treatments Revenue by Application in 2024
5.4.7 Amway Sarcopenia Treatments Revenue by Geographic Area in 2024
5.4.8 Amway Recent Developments
5.5 By-health
5.5.1 By-health Corporation Information
5.5.2 By-health Description, Business Overview
5.5.3 By-health Sarcopenia Treatments Products Offered
5.5.4 By-health Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.5.5 By-health Sarcopenia Treatments Revenue by Product in 2024
5.5.6 By-health Sarcopenia Treatments Revenue by Application in 2024
5.5.7 By-health Sarcopenia Treatments Revenue by Geographic Area in 2024
5.5.8 By-health Recent Developments
5.6 Usana
5.6.1 Usana Corporation Information
5.6.2 Usana Description, Business Overview
5.6.3 Usana Sarcopenia Treatments Products Offered
5.6.4 Usana Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.6.5 Usana Sarcopenia Treatments Revenue by Product in 2024
5.6.6 Usana Sarcopenia Treatments Revenue by Application in 2024
5.6.7 Usana Sarcopenia Treatments Revenue by Geographic Area in 2024
5.6.8 Usana Recent Developments
5.7 A&Z Pharmaceutical
5.7.1 A&Z Pharmaceutical Corporation Information
5.7.2 A&Z Pharmaceutical Description, Business Overview
5.7.3 A&Z Pharmaceutical Sarcopenia Treatments Products Offered
5.7.4 A&Z Pharmaceutical Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.7.5 A&Z Pharmaceutical Sarcopenia Treatments Revenue by Product in 2024
5.7.6 A&Z Pharmaceutical Sarcopenia Treatments Revenue by Application in 2024
5.7.7 A&Z Pharmaceutical Sarcopenia Treatments Revenue by Geographic Area in 2024
5.7.8 A&Z Pharmaceutical Recent Developments
5.8 GlaxoSmithKline
5.8.1 GlaxoSmithKline Corporation Information
5.8.2 GlaxoSmithKline Description, Business Overview
5.8.3 GlaxoSmithKline Sarcopenia Treatments Products Offered
5.8.4 GlaxoSmithKline Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.8.5 GlaxoSmithKline Sarcopenia Treatments Revenue by Product in 2024
5.8.6 GlaxoSmithKline Sarcopenia Treatments Revenue by Application in 2024
5.8.7 GlaxoSmithKline Sarcopenia Treatments Revenue by Geographic Area in 2024
5.8.8 GlaxoSmithKline Recent Developments
5.9 Bayer
5.9.1 Bayer Corporation Information
5.9.2 Bayer Description, Business Overview
5.9.3 Bayer Sarcopenia Treatments Products Offered
5.9.4 Bayer Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.9.5 Bayer Sarcopenia Treatments Revenue by Product in 2024
5.9.6 Bayer Sarcopenia Treatments Revenue by Application in 2024
5.9.7 Bayer Sarcopenia Treatments Revenue by Geographic Area in 2024
5.9.8 Bayer Recent Developments
5.10 H&H
5.10.1 H&H Corporation Information
5.10.2 H&H Description, Business Overview
5.10.3 H&H Sarcopenia Treatments Products Offered
5.10.4 H&H Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.10.5 H&H Sarcopenia Treatments Revenue by Product in 2024
5.10.6 H&H Sarcopenia Treatments Revenue by Application in 2024
5.10.7 H&H Sarcopenia Treatments Revenue by Geographic Area in 2024
5.10.8 H&H Recent Developments
5.11 Blackmores
5.11.1 Blackmores Corporation Information
5.11.2 Blackmores Description, Business Overview
5.11.3 Blackmores Sarcopenia Treatments Products Offered
5.11.4 Blackmores Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.11.5 Blackmores Sarcopenia Treatments Revenue by Product in 2024
5.11.6 Blackmores Sarcopenia Treatments Revenue by Application in 2024
5.11.7 Blackmores Sarcopenia Treatments Revenue by Geographic Area in 2024
5.11.8 Blackmores Recent Developments
5.12 Zhendong Group
5.12.1 Zhendong Group Corporation Information
5.12.2 Zhendong Group Description, Business Overview
5.12.3 Zhendong Group Sarcopenia Treatments Products Offered
5.12.4 Zhendong Group Sarcopenia Treatments Revenue and Gross Margin (2020-2025)
5.12.5 Zhendong Group Sarcopenia Treatments Revenue by Product in 2024
5.12.6 Zhendong Group Sarcopenia Treatments Revenue by Application in 2024
5.12.7 Zhendong Group Sarcopenia Treatments Revenue by Geographic Area in 2024
5.12.8 Zhendong Group Recent Developments
6 North America
6.1 North America Sarcopenia Treatments Market Size YoY Growth 2020-2031
6.2 North America Sarcopenia Treatments Market Facts & Figures by Country (2020-2031)
6.3 North America Sarcopenia Treatments Revenue by Type (2020-2025)
6.4 North America Sarcopenia Treatments Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Sarcopenia Treatments Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Sarcopenia Treatments Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Sarcopenia Treatments Revenue by Type (2020-2025)
7.4 Asia-Pacific Sarcopenia Treatments Revenue by Application (2020-2025)
8 Europe
8.1 Europe Sarcopenia Treatments Market Size YoY Growth 2020-2031
8.2 Europe Sarcopenia Treatments Market Facts & Figures by Country (2020-2031)
8.3 Europe Sarcopenia Treatments Revenue by Type (2020-2025)
8.4 Europe Sarcopenia Treatments Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Sarcopenia Treatments Market Size YoY Growth 2020-2031
9.2 Latin America Sarcopenia Treatments Market Facts & Figures by Country (2020-2031)
9.3 Latin America Sarcopenia Treatments Revenue by Type (2020-2025)
9.4 Latin America Sarcopenia Treatments Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Sarcopenia Treatments Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Sarcopenia Treatments Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Sarcopenia Treatments Revenue by Type (2020-2025)
10.4 Middle East and Africa Sarcopenia Treatments Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Sarcopenia Treatments Supply Chain Analysis
11.2 Sarcopenia Treatments Key Raw Materials and Upstream Suppliers
11.3 Sarcopenia Treatments Clients Analysis
11.4 Sarcopenia Treatments Sales Channel and Sales Model Analysis
11.4.1 Sarcopenia Treatments Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Sarcopenia Treatments Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Sarcopenia Treatments Distributors
12 Sarcopenia Treatments Market Dynamics
12.1 Sarcopenia Treatments Industry Trends
12.2 Sarcopenia Treatments Market Drivers
12.3 Sarcopenia Treatments Market Challenges
12.4 Sarcopenia Treatments Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Nestlé
Pfizer Inc
Amway
By-Health
Usana
A&Z Pharmaceutical
GlaxoSmithKline PLC
Bayer
H&H
Blackmores
Zhendong Group
List of Tables
 Table 1. Global Sarcopenia Treatments Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Sarcopenia Treatments Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Sarcopenia Treatments Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Sarcopenia Treatments Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Sarcopenia Treatments Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Sarcopenia Treatments Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Sarcopenia Treatments Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Sarcopenia Treatments Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Sarcopenia Treatments Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Sarcopenia Treatments Players by Revenue (US$ Million) in 2024
 Table 13. Global Sarcopenia Treatments Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Sarcopenia Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sarcopenia Treatments as of 2024)
 Table 15. Global Sarcopenia Treatments Companies Headquarters
 Table 16. Date of International Companies Enter into Sarcopenia Treatments Market
 Table 17. Global Sarcopenia Treatments Companies Product & Service
 Table 18. Global Sarcopenia Treatments Mergers & Acquisitions, Expansion Plans
 Table 19. Abbott Laboratories Corporation Information
 Table 20. Abbott Laboratories Description and Business Overview
 Table 21. Abbott Laboratories Sarcopenia Treatments Product
 Table 22. Abbott Laboratories Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Abbott Laboratories Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 24. Abbott Laboratories Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 25. Abbott Laboratories Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 26. Abbott Laboratories Recent Developments
 Table 27. Nestlé Corporation Information
 Table 28. Nestlé Description and Business Overview
 Table 29. Nestlé Sarcopenia Treatments Product
 Table 30. Nestlé Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Nestlé Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 32. Nestlé Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 33. Nestlé Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 34. Nestlé Recent Developments
 Table 35. Pfizer Corporation Information
 Table 36. Pfizer Description and Business Overview
 Table 37. Pfizer Sarcopenia Treatments Product
 Table 38. Pfizer Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Pfizer Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 40. Pfizer Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 41. Pfizer Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 42. Pfizer Recent Developments
 Table 43. Amway Corporation Information
 Table 44. Amway Description and Business Overview
 Table 45. Amway Sarcopenia Treatments Product
 Table 46. Amway Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Amway Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 48. Amway Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 49. Amway Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 50. Amway Recent Developments
 Table 51. By-health Corporation Information
 Table 52. By-health Description and Business Overview
 Table 53. By-health Sarcopenia Treatments Product
 Table 54. By-health Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. By-health Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 56. By-health Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 57. By-health Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 58. By-health Recent Developments
 Table 59. Usana Corporation Information
 Table 60. Usana Description and Business Overview
 Table 61. Usana Sarcopenia Treatments Product
 Table 62. Usana Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Usana Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 64. Usana Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 65. Usana Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 66. Usana Recent Developments
 Table 67. A&Z Pharmaceutical Corporation Information
 Table 68. A&Z Pharmaceutical Description and Business Overview
 Table 69. A&Z Pharmaceutical Sarcopenia Treatments Product
 Table 70. A&Z Pharmaceutical Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. A&Z Pharmaceutical Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 72. A&Z Pharmaceutical Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 73. A&Z Pharmaceutical Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 74. A&Z Pharmaceutical Recent Developments
 Table 75. GlaxoSmithKline Corporation Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Sarcopenia Treatments Product
 Table 78. GlaxoSmithKline Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. GlaxoSmithKline Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 80. GlaxoSmithKline Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 81. GlaxoSmithKline Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 82. GlaxoSmithKline Recent Developments
 Table 83. Bayer Corporation Information
 Table 84. Bayer Description and Business Overview
 Table 85. Bayer Sarcopenia Treatments Product
 Table 86. Bayer Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. Bayer Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 88. Bayer Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 89. Bayer Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 90. Bayer Recent Developments
 Table 91. H&H Corporation Information
 Table 92. H&H Description and Business Overview
 Table 93. H&H Sarcopenia Treatments Product
 Table 94. H&H Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. H&H Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 96. H&H Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 97. H&H Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 98. H&H Recent Developments
 Table 99. Blackmores Corporation Information
 Table 100. Blackmores Description and Business Overview
 Table 101. Blackmores Sarcopenia Treatments Product
 Table 102. Blackmores Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Blackmores Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 104. Blackmores Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 105. Blackmores Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 106. Blackmores Recent Developments
 Table 107. Zhendong Group Corporation Information
 Table 108. Zhendong Group Description and Business Overview
 Table 109. Zhendong Group Sarcopenia Treatments Product
 Table 110. Zhendong Group Sarcopenia Treatments Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. Zhendong Group Revenue Proportion of Sarcopenia Treatments by Product in 2024
 Table 112. Zhendong Group Revenue Proportion of Sarcopenia Treatments by Application in 2024
 Table 113. Zhendong Group Revenue Proportion of Sarcopenia Treatments by Geographic Area in 2024
 Table 114. Zhendong Group Recent Developments
 Table 115. North America Sarcopenia Treatments Revenue by Country (2020-2025) & (US$ Million)
 Table 116. North America Sarcopenia Treatments Revenue by Country (2026-2031) & (US$ Million)
 Table 117. North America Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
 Table 118. North America Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
 Table 119. Asia-Pacific Sarcopenia Treatments Revenue by Region (2020-2025) & (US$ Million)
 Table 120. Asia-Pacific Sarcopenia Treatments Revenue by Region (2026-2031) & (US$ Million)
 Table 121. Asia-Pacific Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
 Table 122. Asia-Pacific Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
 Table 123. Europe Sarcopenia Treatments Revenue by Country (2020-2025) & (US$ Million)
 Table 124. Europe Sarcopenia Treatments Revenue by Country (2026-2031) & (US$ Million)
 Table 125. Europe Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
 Table 126. Europe Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
 Table 127. Latin America Sarcopenia Treatments Revenue by Country (2020-2025) & (US$ Million)
 Table 128. Latin America Sarcopenia Treatments Revenue by Country (2026-2031) & (US$ Million)
 Table 129. Latin America Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
 Table 130. Latin America Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
 Table 131. Middle East and Africa Sarcopenia Treatments Revenue by Country (2020-2025) & (US$ Million)
 Table 132. Middle East and Africa Sarcopenia Treatments Revenue by Country (2026-2031) & (US$ Million)
 Table 133. Middle East and Africa Sarcopenia Treatments Revenue by Type (2020-2025) & (US$ Million)
 Table 134. Middle East and Africa Sarcopenia Treatments Revenue by Application (2020-2025) & (US$ Million)
 Table 135. Sarcopenia Treatments Key Raw Materials, Industry Status and Trend
 Table 136. Sarcopenia Treatments Key Raw Materials and Upstream Suppliers
 Table 137. Sarcopenia Treatments Clients Status and Trend
 Table 138. Sarcopenia Treatments Typical Clients
 Table 139. Sarcopenia Treatments Distributors
 Table 140. Sarcopenia Treatments Market Trends
 Table 141. Sarcopenia Treatments Market Drivers
 Table 142. Sarcopenia Treatments Market Challenges
 Table 143. Sarcopenia Treatments Market Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources


List of Figures
 Figure 1. Sarcopenia Treatments Product Picture
 Figure 2. Global Sarcopenia Treatments Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Sarcopenia Treatments Revenue Market Share by Type in 2024 & 2031
 Figure 4. Protein Supplement Product Picture
 Figure 5. Calcium Supplement Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Sarcopenia Treatments Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Sarcopenia Treatments Revenue Market Share by Application in 2024 & 2031
 Figure 9. Online Pharmacies
 Figure 10. Retail Pharmacies
 Figure 11. Sarcopenia Treatments Report Years Considered
 Figure 12. Global Sarcopenia Treatments Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Sarcopenia Treatments Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Sarcopenia Treatments Market Size Market Share by Region: 2024 Versus 2031
 Figure 15. Global Sarcopenia Treatments Revenue Market Share by Region (2020-2031)
 Figure 16. Global Sarcopenia Treatments Revenue Market Share Forecast by Type (2020-2031)
 Figure 17. Global Sarcopenia Treatments Revenue Market Share Forecast by Application (2020-2031)
 Figure 18. Protein Supplement of Sarcopenia Treatments Revenue Market Share by Application, 2024 VS 2031
 Figure 19. Calcium Supplement of Sarcopenia Treatments Revenue Market Share by Application, 2024 VS 2031
 Figure 20. Other of Sarcopenia Treatments Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Sarcopenia Treatments Revenue Share by Company (2024)
 Figure 22. Sarcopenia Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Protein Supplement Revenue Proportion by Company in 2024
 Figure 24. Calcium Supplement Revenue Proportion by Company in 2024
 Figure 25. Other Revenue Proportion by Company in 2024
 Figure 26. North America Sarcopenia Treatments Revenue 2020-2031 (US$ Million)
 Figure 27. North America Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
 Figure 28. North America Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
 Figure 29. Asia-Pacific Sarcopenia Treatments Revenue 2020-2031 (US$ Million)
 Figure 30. Asia-Pacific Sarcopenia Treatments Revenue Market Share by Region (2020-2031)
 Figure 31. Asia-Pacific Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
 Figure 32. Asia-Pacific Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
 Figure 33. Europe Sarcopenia Treatments Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 34. Europe Sarcopenia Treatments Revenue Market Share by Country (2020-2031)
 Figure 35. Europe Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
 Figure 36. Europe Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
 Figure 37. Latin America Sarcopenia Treatments Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Latin America Sarcopenia Treatments Revenue Market Share by Country (2020-2031)
 Figure 39. Latin America Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
 Figure 40. Latin America Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
 Figure 41. Middle East and Africa Sarcopenia Treatments Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Middle East and Africa Sarcopenia Treatments Revenue Market Share by Country (2020-2031)
 Figure 43. Middle East and Africa Sarcopenia Treatments Revenue Market Share by Type (2020-2025)
 Figure 44. Middle East and Africa Sarcopenia Treatments Revenue Market Share by Application (2020-2025)
 Figure 45. Sarcopenia Treatments Supply Chain (Upstream and Downstream Market)
 Figure 46. Global Production Market Share of Sarcopenia Treatments Raw Materials by Region in 2024
 Figure 47. Sarcopenia Treatments Distribution Channels
 Figure 48. Global Sarcopenia Treatments Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 49. Global Sarcopenia Treatments Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 50. Bottom-up and Top-down Approaches for This Report
 Figure 51. Data Triangulation
 Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Sarcopenia Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sarcopenia Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sarcopenia Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Spinal Muscular Atrophy SMA Treatment Market Research Report 2024
Global Myasthenia Gravis Therapies Market Research Report 2024
Muscle Pain Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Spinal Muscular Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cachexia Treatment Market Research Report 2024
Myasthenia Gravis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Obesity Management Market Research Report 2024
Global Back Brace Market Insights Forecast to 2030
Spinal Muscular Atrophy SMA Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Musculoskeletal System Disorder Therapeutics Market Research Report 2024
Global Weight Loss Programs Market Research Report 2024
Sarcoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Neuromuscular Blocking Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Muscle Stimulation Therapy Apparatus Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Limb Paralysis Treatment Market Research Report 2025
Body Posture Correction Medical Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Musculoskeletal Disorder Stem Cell Therapy Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions